In advance of their webinar this Thursday, October 7, Coleen Klasmeier and Jaime Jones consider some of the effects of the final rule. FDA’s final rule to amend its medical […]
About Coleen Klasmeier
This author has not written his bio yet.
But we are proud to say that Coleen Klasmeier contributed 2 entries already.
Entries by Coleen Klasmeier
FDA recently announced that the Office of Prescription Drug Promotion (“OPDP”) initiated a new study on pharmaceutical companies’ interactions with healthcare providers at promotional booths in medical conference exhibit halls. […]